Clinical Evidence & Peer-reviewed Studies • DoseMeRx
https://doseme-rx.com/resources/clinical-evidence
WEBPeer-reviewed Literature . DoseMeRx has demonstrated clear clinical and operational benefits in independent peer-reviewed studies. DoseMeRx increases the proportion of vancomycin patients achieving target AUC24 and the percentage in target therapeutic range. Authors: Luqman Vali, David R Jenkins, Rakesh Vaja, Hussain Mulla | Download Paper.
DA: 17 PA: 58 MOZ Rank: 72